Daily policy & regulation roundup: 6 stories curated October 13, 2026. Lead: fda proposes restrictions on compounding bulk popular weight loss drugs.

The latest in policy & regulation: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: fda proposes restrictions on compounding bulk popular weight loss drugs.
Healthcare software colleagues of mine often describe a recurring discussion they have with their outsourced development teams. They recount that when they try to explain the difference between a billing diagnosis and a clinical diagnosis, the engineers on the other end deliver a common platitude: “a diagnosis is a diagnosis.” That answer is defensible in ... Read More
Follow the full firehose on the HTC Wire, refreshed automatically every day.